---
layout: post
title: "药明生物(02269.HK)遭摩根大通减持198.25万股"
date: 2022-02-14 06:53:25 +0800
categories: gelonghui
tags: 格隆汇新闻
---
<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.02269" data-code="02269|116|5" data-code2="02269|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.02269&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 02269_0" data-code="K 02269|116|5" data-code2="K 02269|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>根据联交所最新权益披露资料显示，2022年2月7日，药明生物(02269.HK)遭JPMorgan Chase & Co。以每股均价81.0187港元减持好仓198.25万股，涉资约1.61亿港元。</p>
 <p>减持后，JPMorgan Chase & Co。最新持好仓数目为420,076,535股，持好仓比例由10.01%下降至9.96%。</p>
 <p align="center"><br/></p><p class="em_media">（文章来源：格隆汇）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202202142274959656>

[返回格隆汇新闻](//finews.withounder.com/category/gelonghui.html)｜[返回首页](//finews.withounder.com/)